Durham-based Atsena Therapeutics, a gene therapy company developing novel treatments to prevent or reverse certain types of inherited blindness, has raised about $24.5 million in private investment and aims to raise about $7.5 million more. Here’s a deep dive into the company and its progress.
Read More
The AgTech Innovation Alliance, an agricultural innovation network spearheaded by California-based nonprofit AgStart, has won a $150,000 Small Business Administration award that includes funds to boost North Carolina’s growing ag tech industry.
Read More
The opening of TARGAN’s headquarters not only marked a significant milestone for TARGAN but also brought attention to the region’s ongoing growth in the life sciences industry.
Read More
Dignify Therapeutics, a pharmaceutical and medical device development company in Research Triangle Park focused on restoring bowel and bladder control for elderly and neurologically impaired people, has added a new compound to its product pipeline.
Read More
Zoetis celebrated Thursday the official opening of its new 78,000-square-foot building in Durham dedicated to diagnostics and biodevices research and development (R&D) to meet the needs of veterinarians, livestock farmers and pet owners.
Read More
The North Carolina Biotechnology Center awarded 31 grants and loans totaling $2,764,811 to universities, life sciences companies and non-profit organizations in the fourth quarter of its fiscal year. Here are the details.
Read More
It’s often said that success doesn’t happen overnight. Consider Durham-based anti-infectives startup ValanBio Therapeutics. The journey that led to the development of its new synthetic antibiotic technology – LPC-233 – began about 40 years ago. And it isn’t over yet.
Read More
Researchers at Wake Forest University have a new far-out location for advancing their work with human organ tissues – the International Space Station.
Read More
The announcement of the Syneos Health sale comes nearly six years after Syneos Health was created by the $7.4 billion merger of INC Research and inVentiv Health in August 2017. Here’s a detailed look at the deal.
Read More
